Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men.

Saved in:
Bibliographic Details
Title: Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men.
Authors: Crawford TB; 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA.; 2Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Nelson T; 3VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT., Karunamuni R; 4Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA., Desai H; 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA.; 2Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hausler R; 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA.; 2Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Teerlink C; 3VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT.; 5Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT., Carter H; 6Division of Medical Genetics, Department of Medicine, University of California, San Diego, La Jolla, CA.; 7Bioinformatics and Systems Biology Program, University of California, San Diego, La Jolla, CA.; 8Moores Cancer Center, University of California, San Diego, La Jolla, CA.; 9Cancer Cell Map Initiative (CCMI), University of California, San Diego, La Jolla, CA.; 10CIFAR, MaRS Centre, Toronto, ON, Canada., Pagadala MS; 11Research Service, VA San Diego Healthcare System, San Diego, CA.; 12Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Alba PR; 3VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT.; 13Division of Epidemiology, Department of Internal Medical, University of Utah School of Medicine, Salt Lake City, UT., DuVall SL; 3VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT.; 5Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT., Danowski ME; 14VA Boston Healthcare System, Boston, MA., Brunette CA; 14VA Boston Healthcare System, Boston, MA.; 15Department of Medicine, Harvard Medical School, Boston, MA., Ratner D; 14VA Boston Healthcare System, Boston, MA., Garraway IP; 16Department of Surgical and Perioperative Care, VA Greater Los Angeles Healthcare System, Los Angeles, CA.; 17Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA., Rose BS; 4Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA.; 11Research Service, VA San Diego Healthcare System, San Diego, CA., Smith JR; 18Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN., Cooney KA; 19Department of Medicine, Duke University School of Medicine, and Duke Cancer Institute, Durham, NC., Vassy JL; 14VA Boston Healthcare System, Boston, MA.; 15Department of Medicine, Harvard Medical School, Boston, MA.; 20Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA.; 21Population Precision Health, Ariadne Labs, Boston, MA., Hauger RL; 11Research Service, VA San Diego Healthcare System, San Diego, CA.; 22Center for Behavior Genetics of Aging, School of Medicine, University of California, San Diego, La Jolla, CA., Lynch JA; 3VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT.; 13Division of Epidemiology, Department of Internal Medical, University of Utah School of Medicine, Salt Lake City, UT., Seibert TM; 4Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA.; 11Research Service, VA San Diego Healthcare System, San Diego, CA.; 23Department of Bioengineering, University of California, San Diego, La Jolla, CA.; 24Department of Radiology, University of California, San Diego, La Jolla, CA.; 25Department of Urology, University of California, San Diego, La Jolla, CA., Maxwell KN; 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA.; 2Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 26Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 27Basser Center for BRCA, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2025 Sep 15; Vol. 23 (10). Date of Electronic Publication: 2025 Sep 15.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-1413
DOI:10.6004/jnccn.2025.7055